Listing on the Nigerian Stock Exchange (NGX) provides companies with numerous benefits, including increased visibility, access to capital, and enhanced credibility.
However, not all companies choose to list due to regulatory requirements, the cost of compliance, and the need for transparency in financial reporting.
For those that do, market capitalization becomes a crucial indicator of their financial health and investor confidence.
In 2024, health companies listed on the NGX demonstrated their financial robustness through their market capitalizations.
This metric, which reflects the total market value of a company’s outstanding shares, provides insights into the company’s size, stability, and market presence.
Methodology
Nairametrics ranked the top health companies based on their market capitalization as of the end of July 2024, using the daily summary of the last day in July 2024, exploring their operations, histories, and positions in the market.
Market Capitalization: N8,332,550,000
Founded in 1957, Neimeth International Pharmaceuticals Plc is a player in Nigeria’s pharmaceutical sector.
The company specializes in the development, manufacturing, and marketing of pharmaceuticals and veterinary products.
With its headquarters in Lagos, Neimeth claims to operate modern production facilities and a widespread distribution network.
The company established the first pharmaceutical manufacturing plant in Nigeria which was located in Aba.
As of July 31 2024, Neimeth’s market capitalization was N8,332,550,000, with shares priced at N1.95.
Neimeth’s product range includes treatments for malaria, diabetes, cardiovascular diseases, and other health conditions.
